News

The American Bar Association makes available its take on the USA's "federal environmental statutes" and their implications for nanotechnology.

The Food Standards Agency in the UK has published its Science Strategy 2005-10

New approaches are needed for predicting the safe dose of novel drugs that are designed to interact with highly specific human targets because existing preclinical toxicology studies may be inadequate.

We applaud a rare bout of honesty.

The IP battlefield is large and diversified. It goes way beyond highly-publicized battles about patenting genes or semi-conductor designs. A case in point is a lawsuit filed July 14 by Materialise nv, a spin-off of Belgium’s Katholieke Universiteit Leuven, against a Swiss-Swedish company, Nobel Biocare.

The EU is surveying the remuneration of researchers.

You have until the end of the month to tell the EU about your "needs in relation to transnational research cooperation and knowledge transfer between public research organisations".

The European Union’s €54 billion research budget for the next seven years may not be approved in time for the beginning of next year – if Slovenia carries out its threat to oppose the funding of stem cell research.

Medical research should benefit from new lectureships for experts in clinical trials.

The technology-transfer unit of Imperial College London, continuing preparations for its stock-market debut on 31 July, said it has completed a £25 million private placement and set a public share price that would value the business at £181 million.